GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $544,000 | +15.3% | 12,507 | +15.3% | 0.03% | +36.4% |
| Q1 2022 | $472,000 | -14.5% | 10,844 | -13.4% | 0.02% | -8.3% |
| Q4 2021 | $552,000 | +54.6% | 12,529 | +29.0% | 0.02% | +26.3% |
| Q4 2020 | $357,000 | -82.1% | 9,712 | -81.6% | 0.02% | -84.4% |
| Q3 2020 | $1,989,000 | -14.2% | 52,854 | -7.0% | 0.12% | -20.3% |
| Q2 2020 | $2,318,000 | -10.9% | 56,812 | -17.3% | 0.15% | -26.4% |
| Q1 2020 | $2,603,000 | -24.7% | 68,696 | -6.6% | 0.21% | -3.3% |
| Q4 2019 | $3,458,000 | +18.8% | 73,586 | +7.9% | 0.22% | +9.1% |
| Q3 2019 | $2,910,000 | +6.7% | 68,184 | +0.1% | 0.20% | +7.1% |
| Q2 2019 | $2,728,000 | -5.8% | 68,148 | -1.7% | 0.18% | -9.4% |
| Q1 2019 | $2,896,000 | +10.7% | 69,299 | +0.6% | 0.20% | -2.4% |
| Q4 2018 | $2,617,000 | -3.8% | 68,901 | +1.7% | 0.21% | +16.2% |
| Q3 2018 | $2,721,000 | +0.4% | 67,738 | +0.7% | 0.18% | -4.8% |
| Q2 2018 | $2,711,000 | +0.1% | 67,257 | -3.0% | 0.19% | -1.1% |
| Q1 2018 | $2,709,000 | +6.3% | 69,319 | -3.5% | 0.19% | +5.6% |
| Q4 2017 | $2,548,000 | -16.6% | 71,813 | -4.6% | 0.18% | -21.1% |
| Q3 2017 | $3,056,000 | -1.2% | 75,269 | +4.9% | 0.23% | -5.4% |
| Q2 2017 | $3,094,000 | +5.3% | 71,754 | +3.0% | 0.24% | 0.0% |
| Q1 2017 | $2,937,000 | +2.6% | 69,671 | -6.3% | 0.24% | -4.7% |
| Q4 2016 | $2,863,000 | -24.9% | 74,337 | -15.9% | 0.25% | -28.5% |
| Q3 2016 | $3,813,000 | -8.4% | 88,424 | -7.9% | 0.35% | -13.0% |
| Q2 2016 | $4,162,000 | +10.0% | 96,034 | +2.9% | 0.41% | +5.7% |
| Q1 2016 | $3,785,000 | +7.7% | 93,334 | +7.2% | 0.38% | +5.5% |
| Q4 2015 | $3,513,000 | -4.6% | 87,059 | -9.1% | 0.36% | -12.3% |
| Q3 2015 | $3,682,000 | +7.4% | 95,753 | +16.4% | 0.42% | +16.9% |
| Q2 2015 | $3,427,000 | -8.1% | 82,265 | +1.8% | 0.36% | -9.6% |
| Q1 2015 | $3,728,000 | +16.2% | 80,782 | +7.6% | 0.39% | +10.7% |
| Q4 2014 | $3,209,000 | +8.4% | 75,067 | +16.6% | 0.36% | +5.6% |
| Q3 2014 | $2,960,000 | +0.2% | 64,401 | +16.6% | 0.34% | +2.4% |
| Q2 2014 | $2,953,000 | +29.5% | 55,229 | +29.4% | 0.33% | +25.6% |
| Q1 2014 | $2,280,000 | -2.4% | 42,671 | -2.5% | 0.26% | -4.4% |
| Q4 2013 | $2,336,000 | -19.0% | 43,748 | -23.9% | 0.27% | -19.2% |
| Q3 2013 | $2,883,000 | -0.5% | 57,477 | -0.9% | 0.34% | -6.4% |
| Q2 2013 | $2,898,000 | – | 57,992 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |